Novel approaches using natural FAO activators like RSV are particularly appealing, due to their proven application for correction of CPT2- and VLCAD-deficiency in patient cells [103,117]. The gene discussed is CPT2; the disease is very long chain acyl-CoA dehydrogenase deficiency.